Home/Filings/4/0001493152-25-000302
4//SEC Filing

Leftwich Scott 4

Accession 0001493152-25-000302

CIK 0001855485other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:25 PM ET

Size

5.6 KB

Accession

0001493152-25-000302

Insider Transaction Report

Form 4
Period: 2024-12-31
Transactions
  • Award

    Common Stock

    2024-12-31+11,68467,774 total
Footnotes (1)
  • [F1]Represents a grant of restricted stock units ("RSUs") on December 31, 2024 (the "Grant Date"), pursuant to the Issuer's 2023 Equity Incentive Plan and subject to the conditions of a Restricted Stock Unit Award Agreement, in a transaction exempt under Rule 16b-3 to the Reporting Person, who is a non-employee director with the Issuer, in connection with a payment in lieu of cash for services during the Issuer's fourth fiscal quarter. Each RSU represents a contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs fully vested on the Grant Date. The price per share at which the grants were issued is $1.15 and was determined based on the Issuer's closing price on December 31, 2024.

Documents

1 file

Issuer

Calidi Biotherapeutics, Inc.

CIK 0001855485

Entity typeother

Related Parties

1
  • filerCIK 0001991668

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:25 PM ET
Size
5.6 KB